Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SenesTech (SNES) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for SenesTech (SNES) over the last 7 years, with Q3 2025 value amounting to $7.3 million.

  • SenesTech's Cash & Equivalents rose 18991.26% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 18991.26%. This contributed to the annual value of $1.3 million for FY2024, which is 7577.39% down from last year.
  • As of Q3 2025, SenesTech's Cash & Equivalents stood at $7.3 million, which was up 18991.26% from $6.1 million recorded in Q2 2025.
  • SenesTech's 5-year Cash & Equivalents high stood at $15.2 million for Q1 2021, and its period low was $1.3 million during Q4 2024.
  • Over the past 5 years, SenesTech's median Cash & Equivalents value was $4.8 million (recorded in 2022), while the average stood at $5.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 91642.09% in 2021, then plummeted by 7577.39% in 2024.
  • Quarter analysis of 5 years shows SenesTech's Cash & Equivalents stood at $9.3 million in 2021, then tumbled by 48.8% to $4.8 million in 2022, then grew by 12.98% to $5.4 million in 2023, then tumbled by 75.77% to $1.3 million in 2024, then surged by 458.53% to $7.3 million in 2025.
  • Its Cash & Equivalents stands at $7.3 million for Q3 2025, versus $6.1 million for Q2 2025 and $1.7 million for Q1 2025.